Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,718 Jan 1 – Oct 25, 2026
- Disclosed funding
- $341.9B 3676 disclosed amounts
- Median round
- $14.6M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| II Interbeing, Inc.Company profile Voice-analysis software and coaching that help sales teams assess delivery and HR teams monitor employee wellbeing. Voice-analysis software and coaching that help sales teams assess delivery and HR teams monitor employee wellbeing. | ~¥50M | FundingUndisclosed | AI | Japan | Investors | |
HVR EnergyCompany profile HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets. HVR Energy develops and operates modular hydrogen refuelling stations and a network for professional fleets and hydrogen-powered light-duty vehicles. Its compact station design can be installed at existing sites and expanded in stages as demand grows, lowering the infrastructure commitment required to serve early hydrogen mobility markets. | €20M | Series A | Mobility | Spain | Investors | |
| A AquaCompany profile Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments. Aqua gives wealth managers and fund sponsors one platform to launch and manage alternative investments. | $15M | Series A | Fintech | United States | Investors | |
MCatalysisCompany profile MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers. MCatalysis develops modular microwave-driven catalytic refining systems that convert distributed hydrocarbon feedstocks, including waste carbon, into drop-in liquid fuels and chemical products for industrial buyers. | $5M | Seed | Climate tech | United Kingdom | Investors | |
| H Provides legal infrastructure for law firms and in-house teams | $550M | Series HSeries C+ | AI | United States | Investors | |
| A AllogeneticsCompany profile Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. Allogenetics is developing a one-time ex vivo gene therapy that modifies donor organs before transplantation, aiming to reduce immune rejection without suppressing the recipient’s immune system. Its lead ALG-115 program is advancing through preclinical and IND-enabling work for lung transplantation. | €3.8M | Pre-Series ASeries A | Biotech | Germany | Investors | |
CloudNCCompany profile CloudNC builds AI software for precision machining, helping machine shops develop CNC programs and quotes faster while keeping machinists in control of final decisions. CloudNC builds AI software for precision machining, helping machine shops develop CNC programs and quotes faster while keeping machinists in control of final decisions. | $20M | Series B extensionSeries B | Industrial tech | United Kingdom | Investors | |
| T TandaCompany profile Workforce software that helps shift-based businesses schedule staff, manage attendance and connect hours worked to payroll and HR records. Workforce software that helps shift-based businesses schedule staff, manage attendance and connect hours worked to payroll and HR records. | Undisclosed | Strategic growth investmentUndisclosed | Business services | Australia | Investors | |
Anemo LabsCompany profile Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening. Anemo Labs is developing an electronic nose that combines proprietary sensors with AI to detect disease-related signals in bodily fluids for non-invasive health screening. | £700K | Pre-seed | Healthtech | United Kingdom | Investors | |
| TT TwoStep TherapeuticsCompany profile A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors. A peptide-targeting platform is advancing conjugate and radioligand therapies for solid tumors. | $62.5M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
161rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
112rounds22led - 3General Catalyst
Tractian, Legora, Different
100rounds12led - 4Lightspeed
Warp Sciences, Different, Zenzap
80rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →